C
Cristina Tassorelli
Researcher at University of Pavia
Publications - 406
Citations - 19055
Cristina Tassorelli is an academic researcher from University of Pavia. The author has contributed to research in topics: Migraine & Medicine. The author has an hindex of 50, co-authored 346 publications receiving 15732 citations. Previous affiliations of Cristina Tassorelli include University of Rochester Medical Center & UniFi.
Papers
More filters
Journal ArticleDOI
Haemodynamic and neurohormonal responsiveness to different stress tests in mitral valve prolapse
G. Micieli,Anna Cavallini,G.V. Melzi d’Eril,Cristina Tassorelli,F. Barzizza,Anna Verri,I. Richichi,G. Nappi +7 more
TL;DR: The data suggest different degrees of autonomic involvement in mitral valve prolapse which may be related to the various degrees of arrhythmia which seem to contribute to their symptoms.
Journal ArticleDOI
Efficacy of galcanezumab in patients with migraine and history of failure to 3-4 preventive medication categories: subgroup analysis from CONQUER study.
Rose Okonkwo,Antje Tockhorn-Heidenreich,Chad Stroud,Marie-Ange Paget,Manjit Matharu,Cristina Tassorelli +5 more
TL;DR: In this paper, the authors report efficacy outcomes from a pre-specified analysis of galanezumab versus placebo in patients with chronic migraine and 3-4 prior preventive medication category failures due to inadequate efficacy (after at least 2 months at maximum tolerated dose), or safety or tolerability reasons.
Journal ArticleDOI
Does MIDAS reduction at 3 months predict the outcome of erenumab treatment? A real-world, open-label trial
Roberto De Icco,G M Vaghi,Marta Allena,Natascia Ghiotto,Elena Guaschino,Daniele Martinelli,Lara Ahmad,Michele Corrado,Federico Bighiani,Federica Tanganelli,Sara Bottiroli,Francescantonio Cammarota,Grazia Sances,Cristina Tassorelli +13 more
TL;DR: In this article , the authors evaluated whether a ≥ 50% MIgraine Disability ASsessment (MIDAS) score reduction at T3 is a reliable predictor of response to one-year erenumab treatment.
Journal ArticleDOI
Erratum to: Botulinum toxin A modifies nociceptive withdrawal reflex in subacute stroke patients (Brain and Behavior, (2018), 8, 9, (e01069), 10.1002/brb3.1069)
Elena Alvisi,Mariano Serrao,Carmela Conte,Enrico Alfonsi,Cristina Tassorelli,Paolo Prunetti,Silvano Cristina,Armando Perrotta,Francesco Pierelli,Giorgio Sandrini +9 more
Journal ArticleDOI
Efficacy, safety and indirect comparisons of lasmiditan, rimegepant, and ubrogepant for the acute treatment of migraine: A systematic review and network meta-analysis of the literature
Francesca Puledda,Samaira Younis,Eva-Maria Huessler,Faraidoon Haghdoost,Marco Lisicki,Peter J. Goadsby,Cristina Tassorelli +6 more
TL;DR: In this article , the authors performed a random-effects network meta-analysis to study the efficacy and safety of newly developed drugs for the acute treatment of migraine attacks, and concluded that lasmiditan 200 mg was the most effective intervention in the treatment of acute migraine attacks.